Immune Checkpoint Inhibition for Melanoma: A Focus on Veterans
Introduction Veterans have been shown to have a higher risk for melanoma compared to the general U.S. population due to…
11/02/2025
Immune Checkpoint Inhibition for Melanoma: A Focus on Veterans
Introduction Veterans have been shown to have a higher risk for melanoma compared to the general U.S. population due to…
|
11/02/2025
Overview of Melanoma in Veterans
Considerations Regarding Epidemiology, Risk Factors, Diagnosis, Prognosis, Survival, and Treatment Introduction Distinct health challenges affect veterans both during and after…
|
10/22/2025
SkylineDx Publishes Landmark MERLIN_001 Trial in JAMA Surgery Validating the Predictive Power of the Merlin CP-GEP Test in Melanoma
Rotterdam, The Netherlands – San Diego, CA – [October 22nd] – SkylineDx today announced that results from its landmark MERLIN_001…
|
|
10/20/2025
Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma
Prescription Drug User Fee Act (PDUFA) target action date set for April 10, 2026 WOBURN, Mass., Oct. 20, 2025 (GLOBE NEWSWIRE) — Replimune…
|
10/14/2025
The Power of Peer Support in Melanoma Survivorship
A melanoma diagnosis can turn life upside down in an instant. While doctors focus on staging, biopsies, and treatment plans,…
|
10/07/2025
You’re Not Out of Options—What To Do After First Line Therapy Fails
Hearing that your treatment for melanoma has stopped working—or that you’ve had to stop because of side effects—can be overwhelming.…
|
09/05/2025
Advocating for Patients: Letter to the FDA on RP1 Treatment Access
Hundreds of patients, families, and friends have shared their stories with AIM at Melanoma about the urgent need for access…
09/04/2025
Hope on the Horizon: Clinical Trials & Progress in Ocular/Uveal Melanoma
AIM at Melanoma, in collaboration with its Canadian partner, the Save Your Skin Foundation, is pleased to present this informative…
08/26/2025
Back to AIM: Advocacy, Walks, and Fall Initiatives in Melanoma
For AIM at Melanoma, August is all about getting ready for a busy September and fall. While August/September is Back…
08/26/2025
Side Effect Central – Cutaneous Squamous Cell Carcinoma and Keratoacanthoma
Side Effect Central is a series of articles designed to help patients with melanoma and their caregivers understand the side…
|
Recent Posts
Jan. 21, 2026
Reflecting on Melanoma Treatment in 2025 and Looking to the Future in 2026
Jan. 13, 2026
The Integrative Care Approach
Jan. 13, 2026
Improved Response to Immunotherapy with COVID-19 mRNA Vaccines
Dec. 09, 2025
One Day at a Time: Caregiving Through Ocular Melanoma
Nov. 24, 2025